Yoneda Kei, Kamiya Naoto, Utsumi Takanobu, Wakai Ken, Oka Ryo, Endo Takumi, Yano Masashi, Hiruta Nobuyuki, Ichikawa Tomohiko, Suzuki Hiroyoshi
Department of Urology, Toho University Sakura Medical Center, 564-1 Shimoshizu, Sakura-shi, Chiba 285-8741, Japan.
Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba-city, Chiba 260-8687, Japan.
Diagnostics (Basel). 2021 Feb 4;11(2):244. doi: 10.3390/diagnostics11020244.
(1) Background: This study aimed to evaluate the associations of lymphovascular invasion (LVI) at first transurethral resection of bladder (TURBT) and radical cystectomy (RC) with survival outcomes, and to evaluate the concordance between LVI at first TURBT and RC. (2) Methods: We analyzed 216 patients who underwent first TURBT and 64 patients who underwent RC at Toho University Sakura Medical Center. (3) Results: LVI was identified in 22.7% of patients who underwent first TURBT, and in 32.8% of patients who underwent RC. Univariate analysis identified ≥cT3, metastasis and LVI at first TURBT as factors significantly associated with overall survival (OS) and cancer-specific survival (CSS). Multivariate analysis identified metastasis (hazard ratio (HR) 6.560, = 0.009) and LVI at first TURBT (HR 9.205, = 0.003) as significant predictors of CSS. On the other hand, in patients who underwent RC, ≥pT3, presence of G3 and LVI was significantly associated with OS and CSS in univariate analysis. Multivariate analysis identified inclusion of G3 as a significant predictor of OS and CSS. The concordance rate between LVI at first TURBT and RC was 48.0%. Patients with positive results for LVI at first TURBT and RC displayed poorer prognosis than other patients ( < 0.05). (4) Conclusions: We found that the combination of LVI at first TURBT and RC was likely to provide a more significant prognostic factor.
(1)背景:本研究旨在评估首次经尿道膀胱肿瘤切除术(TURBT)和根治性膀胱切除术(RC)时的淋巴管侵犯(LVI)与生存结局的相关性,并评估首次TURBT和RC时LVI的一致性。(2)方法:我们分析了东京大学樱花医学中心216例行首次TURBT的患者和64例行RC的患者。(3)结果:首次TURBT患者中22.7%发现有LVI,RC患者中32.8%发现有LVI。单因素分析确定≥cT3、转移和首次TURBT时的LVI是与总生存(OS)和癌症特异性生存(CSS)显著相关的因素。多因素分析确定转移(风险比(HR)6.560,P = 0.009)和首次TURBT时的LVI(HR 9.205,P = 0.003)是CSS的显著预测因素。另一方面,在接受RC的患者中,单因素分析显示≥pT3、G3的存在和LVI与OS和CSS显著相关。多因素分析确定纳入G3是OS和CSS的显著预测因素。首次TURBT和RC时LVI的一致率为48.0%。首次TURBT和RC时LVI结果为阳性的患者预后比其他患者差(P < 0.05)。(4)结论:我们发现首次TURBT和RC时LVI的联合可能是一个更显著的预后因素。